Age and Small Airway Imaging Abnormalities in Subjects with and without Airflow Obstruction in SPIROMICS
- PMID: 27564413
- PMCID: PMC5378423
- DOI: 10.1164/rccm.201604-0871OC
Age and Small Airway Imaging Abnormalities in Subjects with and without Airflow Obstruction in SPIROMICS
Abstract
Rationale: Aging is associated with reduced FEV1 to FVC ratio (FEV1/FVC), hyperinflation, and alveolar enlargement, but little is known about how age affects small airways.
Objectives: To determine if chest computed tomography (CT)-assessed functional small airway would increase with age, even among asymptomatic individuals.
Methods: We used parametric response mapping analysis of paired inspiratory/expiratory CTs to identify functional small airway abnormality (PRMFSA) and emphysema (PRMEMPH) in the SPIROMICS (Subpopulations and Intermediate Outcome Measures in COPD Study) cohort. Using adjusted linear regression models, we analyzed associations between PRMFSA and age in subjects with or without airflow obstruction. We subdivided participants with normal spirometry based on respiratory-related impairment (6-minute-walk distance <350 m, modified Medical Research Council ≥2, chronic bronchitis, St. George's Respiratory Questionnaire >25, respiratory events requiring treatment [antibiotics and/or steroids or hospitalization] in the year before enrollment).
Measurements and main results: Among 580 never- and ever-smokers without obstruction or respiratory impairment, PRMFSA increased 2.7% per decade, ranging from 3.6% (ages 40-50 yr) to 12.7% (ages 70-80 yr). PRMEMPH increased nonsignificantly (0.1% [ages 40-50 yr] to 0.4% [ages 70-80 yr]; P = 0.34). Associations were similar among nonobstructed individuals with respiratory-related impairment. Increasing PRMFSA in subjects without airflow obstruction was associated with increased FVC (P = 0.004) but unchanged FEV1 (P = 0.94), yielding lower FEV1/FVC ratios (P < 0.001). Although emphysema was also significantly associated with lower FEV1/FVC (P = 0.04), its contribution relative to PRMFSA in those without airflow obstruction was limited by its low burden.
Conclusions: In never- and ever-smokers without airflow obstruction, aging is associated with increased FVC and CT-defined functional small airway abnormality regardless of respiratory symptoms.
Keywords: aging; geriatrics; imaging analysis; lung function; spirometry.
Figures
Comment in
-
Reply: Software-assisted Computed Tomography Quantification of Airway Remodeling in the Normal Aging Process.Am J Respir Crit Care Med. 2017 Feb 15;195(4):541. doi: 10.1164/rccm.201610-2168LE. Am J Respir Crit Care Med. 2017. PMID: 28199156 Free PMC article. No abstract available.
-
Software-assisted Computed Tomography Quantification of Airway Remodeling in the Normal Aging Process.Am J Respir Crit Care Med. 2017 Feb 15;195(4):540-541. doi: 10.1164/rccm.201610-2028LE. Am J Respir Crit Care Med. 2017. PMID: 28199160 No abstract available.
References
-
- Lee KW, Chung SY, Yang I, Lee Y, Ko EY, Park MJ. Correlation of aging and smoking with air trapping at thin-section CT of the lung in asymptomatic subjects. Radiology. 2000;214:831–836. - PubMed
-
- Brozek J. Age differences in residual lung volume and vital capacity of normal individuals. J Gerontol. 1960;15:155–160. - PubMed
-
- Fukuchi Y. The aging lung and chronic obstructive pulmonary disease: similarity and difference. Proc Am Thorac Soc. 2009;6:570–572. - PubMed
-
- Faner R, Rojas M, Macnee W, Agustí A. Abnormal lung aging in chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2012;186:306–313. - PubMed
MeSH terms
Grants and funding
- R01 HL130883/HL/NHLBI NIH HHS/United States
- HHSN268200900009C/WH/WHI NIH HHS/United States
- S10 OD018526/OD/NIH HHS/United States
- P30 ES005605/ES/NIEHS NIH HHS/United States
- K08 AG031837/AG/NIA NIH HHS/United States
- K23 HL128936/HL/NHLBI NIH HHS/United States
- U01 HL089897/HL/NHLBI NIH HHS/United States
- HHSN268200900016C/HL/NHLBI NIH HHS/United States
- I01 CX000911/CX/CSRD VA/United States
- U01 HL137880/HL/NHLBI NIH HHS/United States
- HHSN268200900013C/HL/NHLBI NIH HHS/United States
- P01 CA085878/CA/NCI NIH HHS/United States
- HHSN268200900014C/HL/NHLBI NIH HHS/United States
- T32 HL007749/HL/NHLBI NIH HHS/United States
- R01 HL089897/HL/NHLBI NIH HHS/United States
- HHSN268200900019C/HL/NHLBI NIH HHS/United States
- R01 HL089856/HL/NHLBI NIH HHS/United States
- K01 HL118714/HL/NHLBI NIH HHS/United States
- U01 HL089856/HL/NHLBI NIH HHS/United States
- HHSN268200900015C/HL/NHLBI NIH HHS/United States
- R01 HL122438/HL/NHLBI NIH HHS/United States
- R44 HL118837/HL/NHLBI NIH HHS/United States
- HHSN268200900018C/HL/NHLBI NIH HHS/United States
- P30 DK054759/DK/NIDDK NIH HHS/United States
- HHSN268200900017C/HL/NHLBI NIH HHS/United States
- HHSN268200900020C/HL/NHLBI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials
